Research and Markets: Hope for Future of Global OTC Industry If Participants Embrace Change Quickly, Firmly and without Compromise.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com) has announced the addition of New Paradigms New Paradigm In the investing world, a totally new way of doing things that has a huge effect on business. Notes: The word "paradigm" is defined as a pattern or model, and it has been used in science to refer to a theoretical framework. for OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). to their offering. The wheels have come off the wagon: OTC markets Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange over-the-counter market across the world are in recession. Where is the industry going? The industry is stuttering stuttering or stammering, speech disorder marked by hesitation and inability to enunciate consonants without spasmodic repetition. Known technically as dysphemia, it has sometimes been attributed to an underlying personality disorder. and virtually static. The author of this report believes the industry can kick-start itself and accelerate rapidly - but only if change is embraced quickly, firmly and without compromise. This report is all about helping OTC marketers attain the promise of the future, to become masters of their own destiny. The underlying message is that change must - and will - come from inside the industry. New Paradigms For OTC: Visionary Report That Tackles The Crucial Issues - Plain Speaking about where we are today, what went wrong - The Competitive Landscape - is it a two-horse race? - Switch - has the model failed? Where is switch going? - Consumer-Centric Vision - category management from cradle to grave, bringing order out of retail chaos - The Rainbow Effect - harnessing the healthcare professionals, having a million new ambassadors - LESS SKUs, MORE FOCUS - Current brand management values questioned - M&A - Is OTC A Sideshow See Windows SideShow. ? Do mergers and alliances really work? - Critical Mass - Can It Push Up Profitability? - Grasping The Nettle nettle, common name for the Urticaceae, a family of fibrous herbs, small shrubs, and trees found chiefly in the tropics and subtropics. Several genera of nettles are covered with small stinging hairs that on contact emit an irritant (formic acid) which produces a of distribution as the mass market storms on - Why Isn't Technology Driving Success? - The Ideal Otc Organisation - does it exist? Can it exist? - 20/20 Foresight - Options, forecasts, enacting the plan and winning This report consists of twelve challenging and provocative chapters, which define the new paradigms. 1. Current OTC market situation - the plain truth - Recent history, growth trends - Why it didn't happen - The US/rest of world divide - Case studies of success - crumbs CRUMBS is an improvisational theatre duo based in Winnipeg, Manitoba, Canada. The duo consists of two actors, Stephen Sim, and Lee White. Other members include videographers, musicians, photographers, webmasters, illustrators, producers, agents, publicists, graphic of comfort? 2. The competitive landscape - Who's who Who’s Who biographical dictionary of notable living people. [Am. Hist.: Hart, 922] See : Fame - The MNCs - Key regional/local marketers - Winners, survivors and losers - Who's doing well, who's doing badly 3. Switch - Switch in the US after Claritin - Switch internationally - a failed experiment - The next 5 years see a modest revival - And the good news: Advisory OTCs and Collaborative Care 4. New technology - Many disappointments - Case studies of the few real successes - What the future holds 5. Distribution - The mass market storms on - Dealing with powerful chains - The menace of global retailers - Private labels/generics: trick or treat? - New role needed for the private pharmacist pharmacist /phar·ma·cist/ (fahr´mah-sist) one who is licensed to prepare and sell or dispense drugs and compounds, and to make up prescriptions. phar·ma·cist n. - New channels like multilevel mul·ti·lev·el adj. Having several levels: a multilevel parking garage. Adj. 1. multilevel - of a building having more than one level and internet marketing See Internet advertising. 6. Category Management - Where's the R in R&D - Managing brand lifecycle better - Making our brands consumer-centric - Bringing order out of retail chaos 7. The Rainbow Effect - The right mix of consumer and healthcare professional marketing - Niche and ethnic marketing - More targeted advertising - Consumers - do you know their names? - Harnessing the healthcare professionals - A million new ambassadors - store staff, nurses, auxiliaries 8. Managing brands for long-term profit growth - Is the industry already genericised? - Umbrella branding An umbrella brand is a brand that covers diverse kinds of products which are more or less related. It applies also to any company that is identified only by its brand and history. Such a company now only acts as designer and distributor. - more SKUs, less focus - Building brand values, strengthening consumer loyalty - Adding value, raising prices - Is the natural/herbal trend finished? 9. Mergers & Acquisitions - Are OTC acquisitions always a sideshow of the Big Pharma Game? - Do they work? - Margins and multiples 10. OTC Profitability - What is it now? - Future prospects - Building critical mass - is it feasible on a global scale? 11. The ideal OTC organisation - Does it exist? Can it exist? - The perennial matrix debate - country vs global category management - How should OTC relate to pharma? - Business development - on the bridge, or in the engine room? 12. A global vision for OTC - Strategy options - Forecasts: best case/worst case/most likely - Making it work - To be a winner Case Studies included in this report: Case Study No.1: Pepcid Complete Pepcid Complete, comarketed by Johnson & Johnson and Merck, is a combination of the H2-blocker famotidine (10 mg) with the antacids calcium carbonate (800 mg) and magnesium hydroxide (165 mg). It is administered as chewable tablets and used to treat heartburn. (US) Case Study No.2: Sudafed 24 Hours (US) Case Study No.3: Advil Liqui-gels (US) Case Study No.4: Triaminic Softchews (US) Case Study No.5: Listerine PocketPaks (US) Other companies mentioned in this report include: --Johnson & Johnson --GlaxoSmithKline --Pfizer --Wyeth --Bayer --Novartis --"Rochartis --Taisho --Boehringer Ingelheim --Procter & Gamble --Bristol-Myers Squibb For more information visit http://www.researchandmarkets.com/reports/c3870 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion